Hints and tips:
Related Special Reports
...Denmark’s Novo Nordisk Foundation, the Bill & Melinda Gates Foundation and UK-based Wellcome will commit an initial total of $300mn over three years and aim to expand their collaboration to other public,...
...Wellcome Trust announced on Friday that the expansion, expected to cost more than £1bn, would secure the status of its Genome Campus at Hinxton “as a world-leading hub for genomics and biodata”....
...The Wellcome Trust was established in 1936 with legacies from the pharmaceuticals tycoon Henry Wellcome....
...The Wellcome Trust was founded in 1936 after the death of pharmaceutical entrepreneur Sir Henry Wellcome, founder of one of the predecessors to drugmaker GlaxoSmithKline....
...Wellcome Trust warns of private equity ‘shakeout’ Nick Moakes, chief investment officer of the £38bn Wellcome Trust, reckons that the private equity industry is facing a “shakeout” that could result in...
...Some of the most prominent, like the UK’s Wellcome Trust, have divested and diversified. Ownership by a non-profit can constrain expansion....
...Wellcome Trust has given its Wellcome Leap “moonshot” arm almost $700mn, and plans to allocate 5 per cent of its total expenditure, which could take it up to $1bn by 2030, not 2032 as originally stated in...
...The companies said UKCM’s board was “minded to recommend” the deal to shareholders “excluding” chair Peter Pereira Gray, a former head of the investment division for the Wellcome Trust, who is not backing...
...In Novo Nordisk’s case, thanks to the success of GLP-1s, its owner is now bigger than the Bill & Melinda Gates Foundation or the Wellcome Trust, the two other powerhouses of medical research funding and...
...Peel Hunt is a fan of Syncona, a Guernsey-based listed company created out of the Wellcome Foundation’s VC arm....
...The Bill & Melinda Gates Foundation will contribute $400mn to the phase 3 trial while Wellcome Trust provides $150mn....
...The latest £200mn project was a collaboration funded by the government, Wellcome Trust, Britain’s biggest biomedical charity, and four pharmaceutical companies....
...“When we talk about links between climate change and human health, the most obvious thing is extreme heat, and extreme weather events,” says Alan Dangour, head of climate and health at the Wellcome Trust...
...As the pandemic swept through the west in spring 2020, Dugan signed up to a new challenge, building Wellcome Leap, a new “moonshot” arm of the Wellcome Trust, the charitable foundation devoted to health...
...Wellcome Trust, the UK’s largest charitable donor and a large institutional investor, also divested from Vista’s funds following the scandal, people familiar with the matter said....
...Wellcome Trust, Britain’s largest biomedical charity, was not included in the analysis due to its size, which would distort the data set....
...Trust, the charitable foundation....
...Wellcome has set up an office in Berlin “because we wanted to have a presence for advocacy in the EU. We think that continues to be important for Wellcome as a global organisation”....
...“It is important that science collaborates in an efficient manner,” said Martin Smith, head of policy at the Wellcome Trust, the charitable foundation....
...*This article has been amended since original publication to clarify the statements of the Wellcome Trust....
...“If we don’t address those key drivers in the 21st century, we’re going to face more,” said Farrar, who for a decade helmed Britain’s Wellcome Trust, a leading global health institution....
...The £200mn project is a collaboration funded by the government, Wellcome Trust, Britain’s biggest biomedical charity, and four pharma companies....
...It has received sporadic grants for particular projects such as nine non-English language versions of its services and has some core funding, notably from the Wellcome Trust up to 2025....
...Glaxo first bought Wellcome in 1995 and then SmithKline Beecham in 2000, becoming GSK. Glencore acquired Xstrata in 2013....
...We’ve got a great line-up of speakers, including Nick Moakes, chief investment officer of the Wellcome Trust; Nigel Wilson, departing chief executive of Legal and General; and BlackRock’s head of Emea Stephen...
International Edition